| human | Q5 |
| P496 | ORCID iD | 0000-0001-7698-557X |
| P734 | family name | Fahmi | Q5429562 |
| Fahmi | Q5429562 | ||
| Fahmi | Q5429562 | ||
| P735 | given name | Hassan | Q107178443 |
| Hassan | Q107178443 | ||
| P106 | occupation | author | Q482980 |
| researcher | Q1650915 |
| Q41395349 | 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase |
| Q47617068 | ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis |
| Q44801427 | Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. |
| Q42249248 | Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study |
| Q86044160 | Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype |
| Q40220071 | Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal |
| Q38817800 | An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis |
| Q36198434 | Association of cartilage-specific deletion of peroxisome proliferator-activated receptor γ with abnormal endochondral ossification and impaired cartilage growth and development in a murine model |
| Q27325791 | Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo |
| Q53061352 | Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. |
| Q46592131 | Cartilage-specific deletion of prar-gamma in mice results in early endochondral ossification defects and accelerated aging-dependent development of osteoarthritis |
| Q38554617 | Cellular Aging, Senescence and Autophagy Processes in Osteoarthritis |
| Q22000858 | Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study |
| Q24300761 | Contribution of H3K4 methylation by SET‐1A to interleukin‐1–induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes |
| Q50030070 | Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis |
| Q35606373 | Cyclooxygenase-2 and prostaglandins in articular tissues |
| Q37594768 | Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors |
| Q42502519 | Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade |
| Q36245775 | Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor γ expression in human osteoarthritic chondrocytes |
| Q46718128 | Egr-1 mediates the suppressive effect of IL-1 on PPARg expression in human OA chondrocytes |
| Q46277472 | Egr-1 mediates the suppressive effect of IL-1 on PPARγ expression in human OA chondrocytes |
| Q39555020 | Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis |
| Q54647627 | Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. |
| Q93061388 | Empowering the immune fate of bone marrow mesenchymal stromal cells: gene and protein changes |
| Q50979926 | Exacerbation of Aging-Associated and Instability-Induced Murine Osteoarthritis With Deletion of D Prostanoid Receptor 1, a Prostaglandin D2 Receptor. |
| Q46469863 | Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. |
| Q55093349 | Expression of PPARα, β, and γ in the Hartley guinea pig model of primary osteoarthritis. |
| Q44329052 | Expression of peroxisome proliferator-activated receptors α, β, γ, and H- and L-prostaglandin D synthase during osteoarthritis in the spontaneous hartley guinea pig and experimental dog models |
| Q42723818 | Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1. |
| Q46179783 | HDAC4 contributes to IL-1-induced mPGES-1 expression in human synovial fibroblasts through up-regulation of Egr-1 transcriptional activity |
| Q89458193 | High in vivo levels of adipsin lead to increased knee tissue degradation in osteoarthritis: data from humans and animal models |
| Q41830114 | Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis |
| Q64100827 | In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis |
| Q54494658 | In vivo bone-specific EphB4 overexpression in mice protects both subchondral bone and cartilage during osteoarthritis. |
| Q49464004 | In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis |
| Q89505164 | In vivo protective effect of adipsin-deficiency on spontaneous knee osteoarthritis in aging mice |
| Q41871857 | Increased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage |
| Q84099753 | Inhibition of inducible nitric oxide synthase prevents lipid peroxidation in osteoarthritic chondrocytes |
| Q45217520 | Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism |
| Q43161105 | Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. |
| Q40796520 | Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes |
| Q95654745 | Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use |
| Q64981605 | Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges. |
| Q38647615 | NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis |
| Q87899426 | New evidence implicating 4-hydroxynonenal in the pathogenesis of osteoarthritis in vivo |
| Q75221549 | New insights into prostaglandin biology |
| Q36413081 | New thoughts on the pathophysiology of osteoarthritis: one more step toward new therapeutic targets |
| Q42517231 | Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism |
| Q39561045 | Nuclear receptor retinoid-related orphan receptor α1 modulates the metabolic activity of human osteoblasts |
| Q34515090 | PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview. |
| Q43169841 | PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage |
| Q37785802 | Peroxisome proliferator-activated receptor gamma in osteoarthritis |
| Q42109507 | Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes |
| Q41554602 | Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis |
| Q36633235 | Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis |
| Q40726810 | Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes |
| Q45184201 | Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids |
| Q36903199 | Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis' - authors' reply |
| Q93234761 | Role of Lipocalin-type prostaglandin D synthase in experimental osteoarthritis |
| Q84592548 | Role of TL1A in the pathogenesis of rheumatoid arthritis |
| Q37814044 | Role of proinflammatory cytokines in the pathophysiology of osteoarthritis |
| Q46890543 | Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes |
| Q50501926 | Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium. |
| Q34507422 | Systematic review of the association between chronic social stress and telomere length: A life course perspective. |
| Q90114180 | The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells |
| Q115212931 | The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings |
| Q53677153 | The in vivo effect of prophylactic subchondral bone protection of osteoarthritic synovial membrane in bone-specific Ephb4-overexpressing mice. |
| Q80544761 | The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and ca |
| Q54201402 | The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. |
| Q42411918 | The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target |
| Q110596060 | Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization |
| Q83217246 | Valproic acid suppresses interleukin-1ß-induced microsomal prostaglandin E2 synthase-1 expression in chondrocytes through upregulation of NAB1 |
| Q35864732 | mPGES-1 as a novel target for arthritis |
| Q36537631 | mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis |
Search more.